Society for Brain Mapping & Therapeutics

What Society for Brain Mapping & Therapeutics does

Society for Brain Mapping & Therapeutics (SBMT) is a 501(c)(3) and 501(c)(6) non-profit scientific society founded in 2004 and headquartered in Pacific Palisades/Los Angeles, California, that convenes a multidisciplinary global community of physicians, scientists, surgeons, engineers, industry leaders, policymakers, students, and fellows around brain mapping, neurotechnology, therapeutics, artificial intelligence, medical imaging, robotics, and brain/spine/mental health applications. Its core platform comprises the flagship annual NeuroTech Convention (23rd edition held April 2026 in Los Angeles with a Nobel Laureate keynote), the rotating Neuroscience20 (N20) G20 Policy Summit launched in 2014 and now spanning 13 G20 host nations, and the annual Brain Mapping Day at the US Congress in its 13th edition. Educational and translational offerings include CME-accredited programs, BioSkills Labs (NeuroVascular and Spine procedural training), a Fellows and Interns Mentorship Program, the Brain Technology & Innovation Park (BTIP), and the National Center for Nano-Bio-Electronics (NCNBE), supplemented by regional chapters in Brazil, the Middle East, and Latin America and an affiliated 501(c)(3) foundation, the World Brain Mapping Foundation (WBMF).

SBMT's business model is membership- and event-driven. Individual members subscribe at tiered annual rates ranging from $49.99 (students) to $99.99 (health teams) to $300 (principal) and $200 (international principal), with a $4,000 lifetime principal tier; conference registration, corporate sponsorship tiers, and exhibition fees at the NeuroTech Convention and N20 summits provide the second revenue stream, while CME programming, BioSkills Labs, and donations routed through the affiliated WBMF foundation contribute the remainder. Distribution runs through a direct membership channel, a self-serve digital layer (website, iOS/Android mobile apps, Brain Mapping TV on YouTube), and regional chapters acting as channel partners, targeting six persona segments: scientists/researchers, physicians/surgeons, industry/innovators, policymakers, students/fellows, and engineers.

Revenue is not publicly disclosed; SBMT does not raise traditional funding rounds and operates as an independent non-profit with no external parent or private equity ownership. Leadership is concentrated in Founder/Chairman/CEO/Scientific Director Dr. Babak Kateb, who holds equivalent roles across SBMT, WBMF, BTIP, NCNBE, and Aramis Therapeutics, with a small executive team covering operations, membership/partnerships (COO Shiva Rampersad), data/IT (CDO Stephan Themis), executive directorship (Vicky Yamamoto), and a rotating presidency (23rd President Namath Hussain in 2026).

Name

Society for Brain Mapping & Therapeutics

Legal name

Society for Brain Mapping and Therapeutics

Website

https://worldbrainmapping.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

501–1,000 employees

Short description

SBMT is a 501(c)(3) non-profit global scientific society founded in 2004 that convenes physicians, scientists, engineers, policymakers, and industry around brain mapping, neurotechnology, AI, imaging, and mental health through annual conferences, the G20 Neuroscience20 policy summit, CME/BioSkills education, and regional chapters in 100+ countries.

Ownership category

akta.pro rank

Product category

Professional Medical Society

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Community Health, Health Promotion & Behavior Change (SBCC) (BPADAIAL)

akta.pro secondary industries

Science, Technology & Innovation Administration (National R&D Policy) (BPAIAAAK), Management Research Institutes & Doctoral (PhD/DBA) Programs (EDAHAHAO)

Keywords

• Neuroscience research society
• Neurotechnology policy advocacy
• Continuing medical education
• Scientific conferences events
• Brain mapping research

Headquarters

HQ city

Pacific Palisades

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Pricing tiers

Distribution channels5 records

Marketing channels11 records

Core offering

SBMT is a multidisciplinary scientific society that operates an annual NeuroTech Convention, the Neuroscience20 (N20) G20 policy summit, BioSkills Labs hands-on training, CME-accredited educational programs, and a tiered membership program for physicians, scientists, engineers, students, and policymakers. It also runs policy advocacy initiatives such as Brain Mapping Day at the US Congress and supports commercialization of neurotechnologies through the Brain Technology & Innovation Park.

Product overview

The Society for Brain Mapping & Therapeutics (SBMT) operates as a global scientific society and nonprofit organization offering a portfolio of conferences, educational programs, clinical initiatives, and policy advocacy platforms. The core offerings include the Annual NeuroTech Convention (the premier neurotechnology conference), the Neuroscience20 (N20) G20 Policy Summit, and Brain Mapping Day at US Congress as major events. Educational products include BioSkills Labs (hands-on training), Continuing Medical Education (CME), Fellows and Interns Mentorship Program, Women in Neurotech, Kids Corner, and Student Chapters. Clinical programs include the Veterans Health Program and Global Physicians and Scientists humanitarian mission. Research and innovation platforms include the Brain Technology & Innovation Park (BTIP), National Center for Nano-Bio-Electronics (NCNBE), and SBMT Mobile Application. The society is affiliated with the World Brain Mapping Foundation (WBMF) and maintains regional chapters including SBMT Brazil. SBMT offers membership services across multiple tiers to physicians, scientists, students, and professionals in neuroscience and neurotechnology fields.

Differentiator

Problem solved

Functional benefit

Products and services

• Annual NeuroTech Convention Flagship annual congress bringing together physicians, scientists, policymakers, funding agencies, and industry to advance brain and spinal cord mapping and image-guided therapies.
• Neuroscience20 (N20) Summit Global policy summit convening leaders in brain, spine, and mental health across G20 nations to align on neurotechnology policy and accelerate clinical translation.
• Brain Mapping Day at US Congress

Quantifiable outcome

• More than 3 billion people affected by neurological conditions served by the global network
• +1 more outcomes

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature4 records

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/WorldBrainMap
• YouTubeyoutube.com/@brainmappingtv/videos
• Facebookfacebook.com/WorldBrainMapping
• LinkedInlinkedin.com/company/societyforbrainmappingtherapeutics
• Instagraminstagram.com/worldbrainmapping

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Society for Brain Mapping & Therapeutics